Compare NECB & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NECB | SOPH |
|---|---|---|
| Founded | 1934 | 2011 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 310.9M | 367.7M |
| IPO Year | 2021 | 2021 |
| Metric | NECB | SOPH |
|---|---|---|
| Price | $23.73 | $4.85 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $7.00 |
| AVG Volume (30 Days) | 29.5K | ★ 103.6K |
| Earning Date | 04-20-2026 | 03-03-2026 |
| Dividend Yield | ★ 4.19% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 3.25 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $9.76 | $23.09 |
| Revenue Next Year | $11.94 | $19.57 |
| P/E Ratio | $7.36 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $19.27 | $2.58 |
| 52 Week High | $25.18 | $5.70 |
| Indicator | NECB | SOPH |
|---|---|---|
| Relative Strength Index (RSI) | 52.87 | 49.65 |
| Support Level | $22.25 | $4.54 |
| Resistance Level | $24.50 | $4.86 |
| Average True Range (ATR) | 0.62 | 0.27 |
| MACD | 0.06 | 0.05 |
| Stochastic Oscillator | 64.42 | 47.81 |
NorthEast Community Bancorp Inc operates as a community-oriented financial institution. It is principally engaged in the business of attracting deposits and investing those funds into mortgage and commercial loans. It conducts activities throughout the Northeastern United States, including New York, Massachusetts, New Jersey, and Connecticut. The company offers a comprehensive line of banking products and services, including mobile banking as well as commercial real estate loans, commercial construction financing, lines of credit, and term loans. It also offers investment advisory and financial planning services.
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.